Bolio, Don't forget that Amarin and Hikma reached a settlement in the PTAB dispute. A settlement where the parties do not anticipate any further litigation involving the disputed patent? Sleven,
Really like what we saw this week with the script data that Raf provided. I want to wait a couple or three weeks before getting euphoric, because for a while there we were having a situation where we would do good one week and then it would reverse and take away the gains the following week. Hopefully that scenario is done and we are seeing finally the advantage of improved formularies.
Market Data 
Markets 
AI
